NASDAQ$VREX
Varex Imaging Corp · Q3 2025 earnings
Q3 2025 earnings · · After market close · Investor relations
Briefing
Varex Imaging Corp reported its financial results for the third quarter of fiscal year 2025.
Varex Imaging Corp reported revenues of $203.0 million for the three months ended July 4, 2025, a decrease from $209.1 million in the prior year quarter. The company recorded a net loss of $89.1 million, primarily due to a $93.9 million goodwill impairment charge in the Medical segment, resulting in a basic and diluted EPS of $(2.15). Gross profit was $67.5 million with a gross margin of 33.3%.
- Revenues declined 2.9% year-over-year to $203.0 million, with Medical segment at $142.1 million and Industrial at $60.9 million.
- Net loss of $89.1 million driven by $93.9 million goodwill impairment in the Medical reporting unit.
- Operating loss of $80.7 million compared to operating income of $9.3 million in the prior year quarter.
- Cash and cash equivalents stood at $136.4 million with total assets of $1,073.4 million at quarter end.
Headline financials
Revenue & EPS history
Varex Imaging · Revenue · Quarterly
$203M
Revenue by segment
Varex Imaging · $203M total across 2 segments · Q3 2025
- Medical$142M—70.0%
- Industrial$60.9M—30.0%
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 18 quarterly earnings reports
-4.3%
Avg return
Earnings day
-3.4%
Avg return
5 days after
-3.0%
Avg return
30 days after
37%
15 / 41 earnings
Positive
+22.1%
Q1 2021
Best reaction
-34.7%
Q2 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2025 | — | — | — | |
| Q2 2026 | -16.9% | -14.9% | — | |
| Q1 2026 | -3.8% | -4.5% | -23.6% | |
| Q4 2025 | -13.7% | -7.1% | +3.6% | |
| Q2 2025 | -20.5% | -13.9% | -2.7% | |
| Q1 2025 | -19.3% | -11.6% | -15.7% | |
| Q4 2024 | +9.2% | +17.8% | +1.8% | |
| Q3 2024 | -12.2% | -21.2% | -15.6% | |
| Q2 2024 | -6.0% | -4.4% | -6.8% | |
| Q1 2024 | -8.4% | -8.4% | -8.6% | |
| Q4 2023 | +3.1% | +1.7% | +12.7% | |
| Q3 2023 | -3.8% | -2.6% | -15.5% | |
| Q2 2023 | +17.6% | +25.5% | +25.6% | |
| Q1 2023 | -10.0% | -7.2% | -14.6% | |
| Q4 2022 | +3.8% | -1.6% | -10.7% | |
| Q3 2022 | +4.1% | -0.6% | -0.3% | |
| Q2 2022 | +11.5% | +11.5% | +15.8% | |
| Q1 2022 | -5.3% | -8.6% | -4.8% | |
| Q4 2021 | +17.1% | +15.0% | +8.7% | |
| Q3 2021 | +1.9% | +7.3% | +10.2% | |
| Q2 2021 | +2.6% | +2.0% | +6.1% | |
| Q1 2021 | +22.1% | +19.3% | +21.0% | |
| Q4 2020 | -3.2% | +1.0% | +16.6% | |
| Q3 2020 | -21.2% | -21.1% | -34.3% | |
| Q2 2020 | -34.7% | -32.9% | -38.3% | |
| Q1 2020 | -5.3% | -5.3% | -25.3% | |
| Q4 2019 | -9.7% | -7.5% | -3.5% | |
| Q3 2019 | -15.8% | -13.3% | -5.0% | |
| Q2 2019 | -9.1% | -8.1% | -16.4% | |
| Q1 2019 | +15.7% | +8.8% | +15.0% | |
| Q4 2018 | -8.3% | -1.8% | -10.8% | |
| Q3 2018 | -25.7% | -25.5% | -17.8% | |
| Q2 2018 | -1.6% | -0.3% | +1.1% | |
| Q1 2018 | -18.5% | -15.9% | -15.8% | |
| Q4 2015 | -1.2% | -0.2% | +7.2% | |
| Q4 2017 | +1.8% | +2.6% | +10.3% | |
| Q3 2016 | +0.8% | -0.2% | +9.4% | |
| Q3 2017 | -8.2% | -5.1% | +1.3% | |
| Q2 2016 | +0.2% | +0.2% | -3.3% | |
| Q2 2017 | +0.7% | +1.2% | +3.0% | |
| Q1 2017 | -2.4% | -5.1% | -0.3% | |
| Q4 2016 | -2.4% | -5.1% | -0.3% | |
| Q1 2016 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro